| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |